Medication info
Rosuvastatin Calcium and Ezetimibe Tablet 10/20 mg

Rosuvastatin Calcium and Ezetimibe Tablet 10/20 mg

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletRosuvastatin Calcium›20.8mg / 1 tablet
Manufacturer / importer
Medica Korea Co., Ltd.
Appearance
This medication is a pink, rectangular film-coated tablet.
Packaging
30 tablets/box [10 tablets/PTP (Alu-Alu) x 3]
Approval status
Active

MFDS item code 202004136 · Approved 2020.05.29 · Insurance code 646005130

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
This medication is administered once daily, regardless of meals. Patients must continue a standard cholesterol-lowering diet before and during treatment with this medication. The dosage should be adjusted according to the patient’s baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range is 10/5 mg to 10/20 mg once daily. The recommended initial dose is 10/5 mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting this medication or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose adjusted accordingly; the dose may be increased to a maximum of 10/20 mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medication (a combination product containing the same amounts of each active ingredient) for convenience.

Ingredients

Manufacturer
Medica Korea Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL cholesterol
  • elevated apolipoprotein B
  • elevated triglycerides
  • elevated non-HDL cholesterol.
View approved original text

This medication helps lower total cholesterol, LDL cholesterol, apolipoprotein B, triglycerides, and non-HDL cholesterol levels while increasing HDL cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia. It is primarily used as an adjunct to dietary therapy and should be administered in conjunction with an appropriate diet, including restriction of saturated fats and cholesterol. Additionally, it safely considers various risk factors in patients at high risk for atherosclerotic vascular disease due to hypercholesterolemia. It is important to identify and treat secondary causes of dyslipidemia, such as diabetes and hypothyroidism, before taking this medication. Treatment effects are monitored through lipid measurements, and especially in cases of acute coronary events, treatment plans are established through lipid testing upon hospitalization and discharge. This medication aims to reduce the risk of cardiovascular disease and improve health through dyslipidemia management.

How to take

Adult dose

This medication is administered once daily, regardless of meals. Patients must continue a standard cholesterol-lowering diet before and during treatment with this medication. The dosage should be adjusted according to the patient’s baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range is 10/5 mg to 10/20 mg once daily. The recommended initial dose is 10/5 mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting this medication or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose adjusted accordingly; the dose may be increased to a maximum of 10/20 mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medication (a combination product containing the same amounts of each active ingredient) for convenience.

Precautions

This medication may rarely cause muscle damage, leading to muscle pain or, in severe cases, a condition called rhabdomyolysis. This could result in acute kidney failure; therefore, if symptoms such as muscle pain, cramps, or weakness occur, immediate consultation with a physician is required. Particular caution is needed in patients with risk factors for muscle damage, such as severe infections, hypotension, major surgery, trauma, hypothyroidism, or reduced kidney function. It should not be administered to patients with poor liver function or active liver disease, and if liver function tests consistently show abnormalities, the treatment should be discontinued or adjusted. Additionally, this medication should not be used by pregnant women or those who could become pregnant, nor by breastfeeding mothers, and females of childbearing age should use effective contraception while taking this medication. It should also not be administered to patients with certain genetic lactose intolerance. Caution should be exercised for elderly patients, those with a history of alcoholism, liver disease, or reduced kidney function when administering this medication. This medication may interact with other medications, particularly fibrates, cyclosporine, anticoagulants, and certain antibiotics; therefore, caution is necessary when using in combination. Regular liver function and muscle-related tests should be conducted during use, and it is essential to inform healthcare providers of any abnormal symptoms. Symptoms such as dizziness or headache may occur, so care should be taken when driving or operating machinery. This medication has not been established for safety and efficacy in children and is not recommended for use in this group. In case of an overdose, no specific antidote is available, and treatment and supportive therapy based on symptoms are needed, along with liver function and muscle enzyme testing. This medication should be kept out of reach of children, and transferring it to other containers should be avoided.

Side effects

Acute renal failure due to myoglobinuria, rhabdomyolysis, nasopharyngitis, arthralgia, headache, elevated ALT, elevated AST, myalgia, edema, elevated serum bilirubin, acneiform dermatitis, pruritus, dizziness, upper respiratory infection, chest pain, facial swelling, strange feeling, drug intolerance, colorectal polyps, irritable bowel syndrome, esophagitis, drowsiness, neurodegenerative disorders, orthostatic dizziness, migraine, diabetes, glucotoxicity, depression, bronchitis, rhinitis, cystitis, onychomycosis, soft tissue infection, hepatic steatosis, hepatic dysfunction, hepatic toxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, increased blood cholesterol, increased serum alkaline phosphatase, arrhythmia, osteoarthritis, osteoporosis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, diaphoresis, dermatitis, skin burning sensation, skin disorders, alopecia, oropharyngeal pain, nasal congestion, respiratory distress, pelvic pain, breast cysts, eyelid droop, diabetic retinopathy, ear discomfort, renal dysfunction, benign esophageal neoplasm, thrombocytopenia, jaundice, hepatitis, increase in transaminases, Stevens-Johnson syndrome, eosinophilia, and systemic symptoms drug reaction syndrome, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal hepatic failure, cognitive impairment, muscle weakness, headache, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, weakness, diabetes, headache, dizziness, abdominal pain, diarrhea, fatigue, numbness, sensory abnormalities, chest discomfort, loss of appetite, abdominal distension, abnormal liver function tests, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, myopathy, myositis, increased serum creatinine, elevated blood pressure, increased blood urea, increased CPK

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain storage temperatures between 1 degree and 30 degrees Celsius to ensure the medication's effectiveness.

Appearance and packaging

Appearance

This medication is a pink, rectangular film-coated tablet.

Package unit

30 tablets/box [10 tablets/PTP (Alu-Alu) x 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.